National Multiple Sclerosis Society

Disability
Theory and models Disability theory Ableism / Disablism Medical model Social model
Education Mainstreaming Individualized Education Program (IEP) Special needs Special school Special education Learning disability
Therapy Physical Occupational Speech
Societal implications Disability rights movement Inclusion Normalisation People-first language Pejorative terms
Personal assistance Personal care assistant (ADLs) Orthotics and braces Prosthetics Assistive technology Assisted living Mobility aid Physical accessibility Universal design Web accessibility
Socioeconomic assistance Social Security Disability Insurance Supplemental Security Income Ticket to Work Disability Living Allowance Disabled students allowance Disabled Persons Railcard Freedom Pass Assured Income for the Severely Handicapped
Groups Organizations National Telecommuting Institute Society for Disability Studies Disabled Peoples' International (DPI) Visitability
Disabled sports Special Olympics Paralympic Games Deaflympics Invictus Games
Culture Disability in the arts Disability art Disability in the media
Disability portal Disability Lists

The National Multiple Sclerosis Society, is a United States-based, non-profit organization, and its network of chapters nationwide help people affected by multiple sclerosis by funding research, driving change through advocacy, facilitating professional education, and providing programs and services that help people with multiple sclerosis and their families. It is headquartered in New York City.

Founded in 1946, originally under the name Association for Advancement of Research on Multiple Sclerosis,^[1] the National Multiple Sclerosis Society supports more multiple sclerosis research, offers more services for people diagnosed with multiple sclerosis, provides more professional education programs, and furthers more advocacy efforts than any other multiple sclerosis organization in the world.

Fund raising events

Walk MS
Bike MS
Challenge Walk MS
MuckFest MS

BPMS150

What is the BP MS 150?

The BP MS 150 is a two-day fundraising bike ride organized by the National MS Society South Central Region. The BP MS 150 is the largest of the 100 Bike MS events in the United States with 13,000 cyclists and 3,500 volunteers with countless spectators along the route from Houston and at the finish line in Austin. In 2014 the BP MS 150 set a fundraising milestone by raising $20 million to support the mission of the National MS Society to create a world free of MS. The fundraising goal for the 2015 BP MS 150 is $21 million.

History of the BP MS 150

Day One

There are three official start locations for the BP MS 150 in the Houston area each route with a total mileage of varying between 160-180 miles to Austin with breakpoints located every 8 to 15 miles. The ride begins Saturday morning at three convenient starting points:

Tully Stadium in Houston
Rhodes Stadium in Katy
Waller Stadium in Waller

Cyclists follow scenic roads into Bellville for lunch. Day One ends at the Fayette County Fairgrounds in La Grange. There are more than 200 teams that enjoy the overnight celebration at the Fayette County Fairgrounds and Camp St. Mark’s locations in La Grange.

Day Two

On Sunday morning, Club 300 members, riders with MS, and the team who received the Platinum Safety Award lead the start on one of two routes that lead to Bastrop Intermediate School for lunch. Cyclists can choose from one of the 2 exciting routes to Austin*:

Bechtel Challenge Route winds through the rolling terrain of Bastrop and Buescher State Parks
Genzyme One-to-One Express Route (route bypasses the State Parks)

Both routes merge before lunch at the Bastrop Intermediate School.

After lunch at Bastrop Intermediate School, the route takes cyclists into downtown Austin for exciting Finish Line festivities at the State Capitol near the Bob Bullock State History Museum

Research

The National Multiple Sclerosis Society supports and funds research activities spanning all research stages, including early discovery research, translational research that brings promising ideas forward into actual therapeutic solutions for testing, and clinical trials. This unique approach drives the pursuit of all promising avenues that can impact those living with multiple sclerosis. In 2012, the Society invested $44 million in over 350 new and ongoing projects.

References

↑ Sylvia Lawry center for MS research history

External links

Multiple sclerosis and other demyelinating diseases of CNS (G35–G37, 340–341)

Signs and symptoms	Ataxia Depression Diplopia Dysarthria Dysphagia Fatigue Incontinence Neurological fatigue Nystagmus Optic neuritis Pain Uhthoff's phenomenon Dawson's fingers

Diagnosis and evolution following	McDonald criteria Poser criteria EDSS Clinically isolated syndrome

Investigation	Pathophysiology Experimental autoimmune encephalomyelitis

Treatment	Interferon beta 1a Interferon beta 1b Glatiramer acetate Mitoxantrone Natalizumab Fingolimod Teriflunomide Dimethyl fumarate Alemtuzumab Therapies under investigation

Borderline forms	Acute disseminated encephalomyelitis Balo concentric sclerosis Neuromyelitis optica Marburg multiple sclerosis Schilder's disease Tumefactive multiple sclerosis (Autoimmune PNS diseases like Guillain-Barré syndrome and CIDP are normally set apart)

Other	List of people with multiple sclerosis List of multiple sclerosis organizations

This article is issued from Wikipedia - version of the Friday, September 25, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.